Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > RE: Theralase US SHORTING party ( TLTFF )
View:
Post by SouthernTierTom on Dec 16, 2021 11:25pm

RE: Theralase US SHORTING party ( TLTFF )

Historical Short Volume Data for TLTFF
Date Close High Low Volume Short Volume % of Vol Shorted
Dec 15 NA NA NA 201,204 163,221 81.12
Dec 14 NA NA NA 176,525 50,902 28.84
Dec 13 NA NA NA 40,430 36,130 89.36
Dec 10 NA NA NA 185,084 85,720 46.31
Dec 09 NA NA NA 196,635 87,800 44.65
Dec 08 NA NA NA 77,000 50,900 66.10
Dec 07 NA NA NA 567,331 259,124 45.67
Dec 06 NA NA NA 326,328 168,938 51.77
Dec 03 NA NA NA 1,038,430 594,900 57.29
Dec 02 NA NA NA 626,028 408,197 65.20
Dec 01 NA NA NA 382,907 104,471 27.28
Nov 30 NA NA NA 371,694 219,608 59.08
Nov 29 NA NA NA 248,326 182,953 73.67
Nov 26 NA NA NA 91,750 31,800 34.66
Nov 24 NA NA NA 129,512 75,512 58.31
Nov 23 NA NA NA 64,178 2,400 3.74
Nov 22 NA NA NA 348,516 171,816 49.30
Nov 19 NA NA NA 332,140 118,990 35.83
Nov 18 NA NA NA 7,100 2,100 29.58
Nov 17 NA NA NA 70,658 70,658 100.00
Comment by Infinity on Dec 17, 2021 4:32am
I am guessing approx 52% of the TLTFF shares were shorted over a period of 20 days period.  This appears to be a huge %.  I am not an expert in short sales, could some one share their insight.  When the short sale happens, the seller would have to buy back within a certain period of time??.  If the 52% number of shares are shorted, there appears to be no other activity going on ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250